A Phase 3, Open-Label, Randomized Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Project: Research

Project Details

StatusFinished
Effective start/end date17/11/23 → 17/11/25

Keywords

  • clinical trial
  • Leukemia
  • Zanubrutinib
  • Venetoclax

Clinical Trial Phase

  • Phase III (a & b)